CJC-1295 + Ipamorelin Blend

This research blend combines:

• CJC-1295 DAC (Drug Affinity Complex) – a 29-amino-acid GHRH analog with extended half-life via albumin-binding DAC technology
• Ipamorelin – a highly selective 5-amino-acid ghrelin mimetic that triggers acute GH pulses

This blend is intended for research use only and is not for human use. It is designed for controlled laboratory investigation of GH/IGF-1 signaling pathways, combining sustained GHRH receptor engagement from CJC-1295 DAC with pulsatile ghrelin receptor activation from Ipamorelin. For research into neuroendocrine and somatotropic axis signaling mechanisms.

Key Scientific Data

• High-purity CJC-1295 DAC (≥ 98%) + Ipamorelin (≥ 98%) verified by HPLC/MS
• Verified sequences: CJC-1295 DAC (Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Maleimidopropionyl)-NH₂) + Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH₂)
• Lyophilized dual-vial or pre-mixed blend for maximum stability
• Full Certificate of Analysis (COA) for each component and blend ratio
• Manufactured in GMP-aligned, ISO-compliant facilities
• Suitable for GH axis, IGF-1 signaling, and synergistic secretagogue research

Research-Referenced Attributes (Based on scientific literature; not therapeutic claims. For Research Use Only. Not for human use.)

• Synergistic GH release observed in human and rodent research models when peptides are combined, as noted in published preclinical studies
• Sustained IGF-1 signaling observed in preclinical models following CJC-1295 DAC administration, with additional pulsatile activity from Ipamorelin
• Minimal cortisol, prolactin, or ACTH perturbation observed in preclinical secretagogue studies — supporting a selective GH signaling profile
• Studied in preclinical models in the context of body composition, bone density, lipid oxidation, and sleep physiology research
• Investigated in the context of tissue repair, immune signaling, and collagen synthesis in laboratory settings
• Referenced in research contexts involving sarcopenia, cachexia, and recovery biology

Why Researchers Choose This CJC-1295 + Ipamorelin Blend

• Widely referenced GH-axis research blend
• Exact sequence match with literature-referenced structures
• Transparent analytical data: HPLC ≥98%, MS confirmation
• Used in endocrinology and physiology laboratory research settings
• Competitive pricing with bulk options

For Research Use Only. Not for human use.